When Damiano Currado began studying sleep patterns among his psoriasis patients in Rome, he noticed something that standard assessments were missing. The global sleep scores looked acceptable on paper, but when Currado and his colleagues at the University of Rome Campus Biomedico dug deeper, they found that patients with more severe psoriasis were struggling with specific aspects of sleep — and those struggles were being overlooked.
Their study, published in the Journal of Clinical Medicine, analyzed 136 consecutive psoriasis patients and found that higher disease activity was independently linked to impairment in particular sleep domains, even when overall sleep quality appeared normal. "These findings highlight the importance of assessing domain-specific sleep disturbances and support the integration of sleep outcomes into a holistic, patient-centered approach to PsO management," the researchers write.
The median Psoriasis Area and Severity Index score among participants was 2, indicating predominantly low disease activity, with a median global Pittsburgh Sleep Quality Index score of 5 — classified as borderline impairment. But patients with PASI scores of 10 or higher showed significantly worse sleep latency (how long it takes to fall asleep) and greater daytime dysfunction. When researchers adjusted for confounders, a PASI score of 10 or above was independently associated with increased sleep latency and daytime sleepiness, even though global sleep scores didn't differ significantly from milder cases.
The implication is straightforward: doctors monitoring psoriasis severity may need to ask more targeted questions about sleep — not just "how are you sleeping?" but specifically about how long it takes to fall asleep and how refreshed patients feel during the day. By catching these domain-specific disturbances, clinicians could intervene earlier and improve quality of life in ways that a single global score would miss.
The findings add weight to a growing movement in dermatology toward treating psoriasis as part of a person's whole health picture rather than focusing solely on skin symptoms. Currado's team suggests that integrating sleep assessments into routine care could help bridge the gap between disease severity and daily functioning — a small shift that could make a meaningful difference for millions living with the condition.